
Journal of Medicinal Chemistry p. 190 - 194 (1991)
Update date:2022-08-03
Topics:
Halfpenny, Paul R.
Horwell, David C.
Hughes, John
Humblet, Christine
Hunter, John C.
et al.
This paper describes the synthesis and κ and μ opioid receptor binding affinity of some conformationally restrained derivatives of the arylacetamide group in the selective κ opioid receptor agonist (+/-)-trans-N-methyl-N-<2-(1-pyrrolidinyl)cyclohexyl>benzothiophene-4-acetamide monohydrochloride (1, PD117302), which is an analogue of U-50,488.The methyl-substituted derivatives (+/-)-trans-N,α-dimethyl-N-<2-(1-pyrrolidinyl)cyclohexyl>benzothiophene-4-acetamide monohydrochloride (6a,b) possess significantly weaker affinity than 1 for the κ opioid receptor (Ki = 172 and 3.7 nM, respectively).It is proposed that this is due to the conformational restriction imposed by the methyl group of 6.In order to test this proposal the acenaphthene derivative and the 4,5-dihydro-3H-naphtho<1,8-bc>thiophene derivative were prepared.The acenaphthene derivative (+)-N-methyl-N-<7-(1-pyrrolidinyl)-1-oxaspiro<4.5>dec-8-yl>acenaphthenecarboxamide monohydrochloride (9) was found to have high κ opioid receptor affinity and selectivity (κ Ki = 0.37 +/- 0.05 nM, μ/κ = 659, δ/κ = 1562) and is 100 times more potent than morphine as an analgesic in the rat paw pressure test for analgesia after intravenous administration (MPE50 = 0.014 and 1.4 mg/kg, respectively).The 4,5-dihydro-3H-naphtho<1,8-bc>thiophene derivative (-)-4,5-dihydro-N-methyl-N-<7-(1-pyrrolidinyl)-1-oxaspiro<4.5>dec-8-yl>-3H-naphtho<1,8-bc>thiophene-5-carboxamide p-toluenesulfonate (17) also has high κ opioid receptor affinity and selectivity (κ Ki = 4.65 nM, μ/κ = 109).
View MoreFUJIAN SHANSHUI CHEMICAL CORP.LTD.
Contact:+86-151-59920036
Address:Jinqiao Gareden, jo@fj-xinyi.com
website:http://www.jairadhesales.com
Contact:0091-79-26431096
Address:309 Harikrupa Tower,Nr old Sharda Mandir Char Rasta,Ellisbridge
Wuhan Zenuo Biological Medicine Technology Co Ltd
website:http://www.znobio.com/a/lianxiwomen/
Contact:(+86-27)8700-2750
Address:Floor 19th,No.76,Longyang Road
Chengdu D-Innovation Pharmaceutical Co., Ltd
Contact:86-28-85105536
Address:1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone
Doi:10.1002/anie.202100051
(2021)Doi:10.1021/ja00722a074
(1970)Doi:10.1002/cmdc.201500443
(2016)Doi:10.3390/molecules20045625
(2015)Doi:10.1039/C29700001374
(1970)Doi:10.1039/c6cc04397f
(2016)